Home > Insider Trading > Filing (0001573202-17-000009)

Filing Details

Accession Number:: 0001573202-17-000009
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-12-12 18:49:47
Reporting Period:: 2017-09-13

Accepted Time:: 2017-12-12 18:49:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
849636	Respirerx Pharmaceuticals Inc.	RSPI	Pharmaceutical Preparations (2834)	330303583

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1236365	J S James Manuso	C/O Respirerx Pharmaceuticals Inc. 126 Valley Road, Suite C Glen Rock NJ 07452	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-09-13	1,097	$0.00	74,252	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2017-09-13	2,195	$0.00	2,195	$6.83
Common Stock	Common Stock Options (to purchase shares of Common Stock)	Acquisiton	2017-12-09	608,704	$0.00	608,704	$1.45

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,195	2015-09-15	2020-09-30	No	4	P	Direct
608,704		2022-12-09	No	4	J	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Common Stock Options (to purchase shares of Common Stock)	$2.00		2022-06-30	50,000	50,000	Direct
Commmon Stock	Common Stock Options (to purchase shares of Common Stock)	$3.90		2022-01-17	75,000	75,000	Direct
Common Stock	COmmon Stock Warrants (right to buy)	$6.83	2016-04-07	2020-09-30	36,578	36,578	Direct
Common Stock	Common Stock Warrants (right to buy)	$6.50	2016-02-04	2019-02-04	8,093	8,093	Direct
Common Stock	Common Stock Options (to purchase shares of Common Stock)	$7.38		2021-03-31	81,539	81,539	Direct
Common Stock	Common Stock Options (to purchase shares of Common Stock)	$6.40		2025-08-18	15,634	15,634	Direct
Common Stock	Common Stock Options (to purchase shares of Common Stock)	$6.40		2025-08-18	246,154	246,154	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2022-06-30	50,000	50,000	Direct
2022-01-17	75,000	75,000	Direct
2020-09-30	36,578	36,578	Direct
2019-02-04	8,093	8,093	Direct
2021-03-31	81,539	81,539	Direct
2025-08-18	15,634	15,634	Direct
2025-08-18	246,154	246,154	Direct

Footnotes

Dr. Manuso purchased shares and warrants in a private transaction for an aggregate of $5,000, or $4.56 per unit, with each unit consisting of one share and warrants to purchase two additional shares of the Company's common stock.
On December 9, 2017, Dr. Manuso forgave all of the accrued but unpaid compensation to which, pursuant to his employment agreement, he was entitled as of September 30, 2017, an aggregate of $878,360. On that date, the Company granted to Dr. Manuso options to purchase 608,704 shares of the Company's common stock, with a black-scholes value of $1.44 per option and an aggregate value of $878,360. These Common Stock Options vested upon issuance.
These Common Stock Options vested upon issuance.
These Common Stock Options vested in three installments: 25 percent on January 18, 2017 (the grant date), 25 percent on March 31, 2017, and 50 percent on June 30, 2017, and are all currently vested.
The exercise price and number of shares of these securities have been adjusted to reflect the Company's 325-to-1 reverse stock split effective September 1, 2016.
These Common Stock Options vested in four equal installments: 25 percent on March 31, 2016 (the grant date), 25 percent on June 30, 2016, 25 percent on September 30, 2016, and 25 percent on December 31, 2016, and are all currently vested.
These Common Stock Options vested in three installments: 50 percent on August 18, 2015 (the grant date), 25 percent on February 18, 2016, and 25 percent on August 18, 2016, and are all currently vested.